Patient presents with a history of cerebrovascular accident (CVA), confirmed by previous imaging (specify type and date if available), resulting in residual neurological deficits.  The patient reports persistent symptoms consistent with post-stroke sequelae, including (specify affected areas such as motor function, sensory perception, cognitive abilities, speech, swallowing, vision, balance, and emotional status).  Assessment reveals (describe specific findings such as hemiparesis, hemiplegia, aphasia, dysarthria, ataxia, sensory loss, cognitive impairment, emotional lability, dysphagia, visual field deficits, or other relevant observations).  These deficits impact the patient's activities of daily living (ADLs) and instrumental activities of daily living (IADLs), requiring (specify level of assistance needed and any assistive devices used).  Current medications include (list all medications, including those related to stroke prevention, management of comorbidities, and symptom control).  The patient's medical history also includes (list relevant comorbidities such as hypertension, diabetes, hyperlipidemia, atrial fibrillation, or other cardiovascular risk factors).  The current treatment plan focuses on managing residual symptoms, maximizing functional recovery through (specify therapies such as physical therapy, occupational therapy, speech therapy, cognitive rehabilitation), and secondary stroke prevention.  Patient education provided on lifestyle modifications including diet, exercise, and medication adherence.  Follow-up scheduled for (specify date and reason).  Diagnosis: History of stroke (I69.3), residual neurological deficits (specify relevant ICD-10 codes for specific deficits).  Prognosis:  (describe anticipated functional outcome based on current deficits and response to therapy).  Plan to monitor for complications such as recurrent stroke, depression, and pain management.